author-photo

David J. Wustrow

Parke-Davis

23

Papers

635

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Abstract 3153: Targeting the stress response kinase GCN2 to restore immunity in the tumor microenvironment

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1646: Development of small-molecule HPK1 inhibitors to unleash tumor-specific T cell responses

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as Single Agent and in Combination with Checkpoint Inhibitors

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (5)
561 Development and first-in-human characterization of a potent oral CCR4 antagonist for the treatment of atopic dermatitis

2020 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (1)
Novel Small Molecule Neurotensin Antagonists: 3-(1,5-Diaryl-1,5- dioxopentan-3-yl)benzoic Acids.

2010 ChemInform
Show All
- Source
- Cite
- Save
Citations (0)
Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one

2003 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (6)
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects

2000 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (10)
3-substituted GABA analogs with central nervous system activity: a review.

1999 Medicinal Research Reviews
- Justin S. Bryans
- David J. Wustrow
Show All
- Source
- Cite
- Save
Citations (262)
Reductive cleavage of resin bound arylsulfonates

1998 Tetrahedron Letters
Show All
- Source
- Cite
- Save
Citations (25)
Isoindolinone enantiomers having affinity for the dopamine D4 receptor.

1998 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (166)